Shigeki Kameyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shigeki Kameyama has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Masuda
Department of Functional Neurosurgery, Nishi-Niigata Chuo National Hospital, Niigata, Japan
8 shared publications- Akiyoshi Kakita
Department of Neuropathology, Brain Research Institute, Niigata University, Niigata, Japan
5 shared publications Osamu Kanazawa
5 shared publicationsMutsuo Sasagawa
Neuropsychiatry, Epilepsy Center, Nishi‐Niigata Chuo National Hospital, Niigata, Japan
4 shared publicationsHiroatsu Murakami
3 shared publicationsManabu Wachi
Epilepsy Center, NishiNiigata Central National Hospital, Niigata, Japan
3 shared publications
Latest Publications
- Open Access
- 21 November 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 420, 117228
Location of emotional corticobulbar tract in the internal capsule
- 21 November 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 420, 117228
Open AccessLocation of emotional corticobulbar tract in the internal capsule
- 1 July 2016
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (7) , 2706-2707
Reply to “The origin of the abnormal muscle response seen in hemifacial spasm remains controversial”
- 1 July 2016
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (7) , 2706-2707
Reply to “The origin of the abnormal muscle response seen in hemifacial spasm remains controversial”
- 1 May 2016
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (5) , 2240-2245
Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm
- 1 May 2016
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (5) , 2240-2245
Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm
- 1 May 2016
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 124 (5) , 1503-1512
MRI-guided stereotactic radiofrequency thermocoagulation for 100 hypothalamic hamartomas
OBJECT: The aim of this study was to elucidate the invasiveness, effectiveness, and feasibility of MRI-guided stereotactic radiofrequency thermocoagulation (SRT) for hypothalamic hamartoma (HH). METHODS: The authors examined the clinical records of 100 consecutive patients (66 male and 34 female) with intractable gelastic seizures (GS) caused by HH, who underwent SRT as a sole surgical treatment between 1997 and 2013. The median duration of follow-up was 3 years (range 1–17 years). Seventy cases involved pediatric patients. Ninety percent of patients also had other types of seizures (non-GS). The maximum diameter of the HHs ranged from 5 to 80 mm (median 15 mm), and 15 of the tumors were giant HHs with a diameter of 30 mm or more. Comorbidities included precocious puberty (33.0%), behavioral disorder (49.0%), and mental retardation (50.0%). RESULTS: A total of 140 SRT procedures were performed. There was no adaptive restriction for the giant or the subtype of HH, regardless of any prior history of surgical treatment or comorbidities. Patients in this case series exhibited delayed precocious puberty (9.0%), pituitary dysfunction (2.0%), and weight gain (7.0%), besides the transient hypothalamic symptoms after SRT. Freedom from GS was achieved in 86.0% of patients, freedom from other types of seizures in 78.9%, and freedom from all seizures in 71.0%. Repeat surgeries were not effective for non-GS. Seizure freedom led to disappearance of behavioral disorders and to intellectual improvement. CONCLUSIONS: The present SRT procedure is a minimally invasive and highly effective surgical procedure without adaptive limitations. SRT involves only a single surgical procedure appropriate for all forms of epileptogenic HH and should be considered in patients with an early history of GS.
- 1 May 2016
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 124 (5) , 1503-1512
MRI-guided stereotactic radiofrequency thermocoagulation for 100 hypothalamic hamartomas
OBJECT: The aim of this study was to elucidate the invasiveness, effectiveness, and feasibility of MRI-guided stereotactic radiofrequency thermocoagulation (SRT) for hypothalamic hamartoma (HH). METHODS: The authors examined the clinical records of 100 consecutive patients (66 male and 34 female) with intractable gelastic seizures (GS) caused by HH, who underwent SRT as a sole surgical treatment between 1997 and 2013. The median duration of follow-up was 3 years (range 1–17 years). Seventy cases involved pediatric patients. Ninety percent of patients also had other types of seizures (non-GS). The maximum diameter of the HHs ranged from 5 to 80 mm (median 15 mm), and 15 of the tumors were giant HHs with a diameter of 30 mm or more. Comorbidities included precocious puberty (33.0%), behavioral disorder (49.0%), and mental retardation (50.0%). RESULTS: A total of 140 SRT procedures were performed. There was no adaptive restriction for the giant or the subtype of HH, regardless of any prior history of surgical treatment or comorbidities. Patients in this case series exhibited delayed precocious puberty (9.0%), pituitary dysfunction (2.0%), and weight gain (7.0%), besides the transient hypothalamic symptoms after SRT. Freedom from GS was achieved in 86.0% of patients, freedom from other types of seizures in 78.9%, and freedom from all seizures in 71.0%. Repeat surgeries were not effective for non-GS. Seizure freedom led to disappearance of behavioral disorders and to intellectual improvement. CONCLUSIONS: The present SRT procedure is a minimally invasive and highly effective surgical procedure without adaptive limitations. SRT involves only a single surgical procedure appropriate for all forms of epileptogenic HH and should be considered in patients with an early history of GS.
- 31 December 2010
- Published by Elsevier in Neuroscience Research
- Vol. 68, e99
Electrocorticographic mapping of human ventral visual areas
- 31 December 2010
- Published by Elsevier in Neuroscience Research
- Vol. 68, e99
Electrocorticographic mapping of human ventral visual areas
- 31 December 2010
- Published by Elsevier in Neuroscience Research
- Vol. 68, e381-e382
Neural decoding of visual object categories using temporal patterns of ECoG signals
- 31 December 2010
- Published by Elsevier in Neuroscience Research
- Vol. 68, e381-e382
Neural decoding of visual object categories using temporal patterns of ECoG signals
- Open Access
Ictogenesis and symptomatogenesis of gelastic seizures in hypothalamic hamartomas: An ictal SPECT study
Summary: Purpose: To topographically localize the ictogenic zone within hypothalamic hamartomas (HHs) and the symptomatogenic zone for gelastic seizure (GS), we analyzed data from both interictal and ictal single photon emission computed tomography (SPECT).Methods: Ictal SPECT was performed immediately after GS onset in 21 patients with HH (aged 2–36 years, mean 13.8 years) who underwent stereotactic radiofrequency thermocoagulation (SRT). SPECT data were statistically analyzed by means of subtraction ictal SPECT coregistered to magnetic resonance imaging (MRI) (SISCOM) and statistical parametric mapping (SPM). Topographic localization of ictal hyperperfusion areas was evaluated.Results: SISCOM obtained in 27 studies demonstrated ictal hyperperfusion in the HH interface zone in 16 studies of 13 patients (hot HH group). In these patients, HHs were significantly larger than those without hyperperfusion of HH in 11 studies of 8 patients (21.4 ± 10.3 vs. 12.3 ± 7.3 mm in diameter, p < 0.05,t‐test). In all patients and in the hot HH group, SPM group analysis of individual differences between interictal and ictal data revealed significantly (p < 0.001) hyperperfused areas in the ipsilateral hypothalamus, mediodorsal (MD) nucleus of the thalamus and putamen, bilateral pontine tegmentum, and contralateral inferior semilunar lobule of the cerebellum. There was no hyperperfusion in the mammillothalamocingulate pathway.Discussion: The present study confirmed that ictogenesis occurs in the HH interface zone, which should accordingly be the target for SRT. We suggest that a thalamopontocerebellar circuit plays an important role for stereotypical and automatic symptomatogenesis of GS and that the hypothalamus and MD nucleus of the thalamus are potentially involved in epileptic encephalopathy.
Open AccessIctogenesis and symptomatogenesis of gelastic seizures in hypothalamic hamartomas: An ictal SPECT study
Summary: Purpose: To topographically localize the ictogenic zone within hypothalamic hamartomas (HHs) and the symptomatogenic zone for gelastic seizure (GS), we analyzed data from both interictal and ictal single photon emission computed tomography (SPECT).Methods: Ictal SPECT was performed immediately after GS onset in 21 patients with HH (aged 2–36 years, mean 13.8 years) who underwent stereotactic radiofrequency thermocoagulation (SRT). SPECT data were statistically analyzed by means of subtraction ictal SPECT coregistered to magnetic resonance imaging (MRI) (SISCOM) and statistical parametric mapping (SPM). Topographic localization of ictal hyperperfusion areas was evaluated.Results: SISCOM obtained in 27 studies demonstrated ictal hyperperfusion in the HH interface zone in 16 studies of 13 patients (hot HH group). In these patients, HHs were significantly larger than those without hyperperfusion of HH in 11 studies of 8 patients (21.4 ± 10.3 vs. 12.3 ± 7.3 mm in diameter, p < 0.05,t‐test). In all patients and in the hot HH group, SPM group analysis of individual differences between interictal and ictal data revealed significantly (p < 0.001) hyperperfused areas in the ipsilateral hypothalamus, mediodorsal (MD) nucleus of the thalamus and putamen, bilateral pontine tegmentum, and contralateral inferior semilunar lobule of the cerebellum. There was no hyperperfusion in the mammillothalamocingulate pathway.Discussion: The present study confirmed that ictogenesis occurs in the HH interface zone, which should accordingly be the target for SRT. We suggest that a thalamopontocerebellar circuit plays an important role for stereotypical and automatic symptomatogenesis of GS and that the hypothalamus and MD nucleus of the thalamus are potentially involved in epileptic encephalopathy.
- 1 September 2009
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 65 (3) , 438-449
MINIMALLY INVASIVE MAGNETIC RESONANCE IMAGING-GUIDED STEREOTACTIC RADIOFREQUENCY THERMOCOAGULATION FOR EPILEPTOGENIC HYPOTHALAMIC HAMARTOMAS
To validate the safety and efficacy of magnetic resonance imaging (MRI)-guided stereotactic radiofrequency thermocoagulation (SRT) for epileptogenic hypothalamic hamartoma (HH), we evaluated surgical outcomes and revised the MRI classification. We retrospectively reviewed 25 consecutive patients with HH (age range, 2-36 years; mean age, 14.8 years) with gelastic seizures. Other seizure types were exhibited in 22 patients (88.0%), precocious puberty in 8 (32.0%), behavioral disorder in 10 (40.0%), and mental retardation in 14 (56.0%). We classified HH into 3 subtypes according to coronal MRI: intrahypothalamic, parahypothalamic, and mixed hypothalamic type. Maximum diameter ranged from 8 to 30 mm (mean, 15.3 mm). All patients underwent SRT (74 degrees C, 60 seconds) for HH. HH subtype and size were correlated with precocious puberty, mental retardation, and behavioral disorder. Thirty-one SRT procedures were performed, requiring 1 to 8 tracks (mean, 3.8 tracks) and involving 1 to 18 lesions (mean, 7.2 lesions). There were no adaptive limitations, regardless of size or subtype. Mixed-type HHs needed more tracks and more lesions. No permanent complications persisted after SRT, and gelastic seizures disappeared in all but 2 patients. Complete seizure freedom was achieved in 19 patients (76.0%). These patients had not only disappearance of all seizure types and behavioral disorder but also intellectual improvement. The present SRT procedure has favorable efficacy and invasiveness and has no adaptive limitations. SRT should therefore be considered before adulthood. The new HH classification is useful to understand clinical symptoms and to determine surgical strategies.
- 1 September 2009
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 65 (3) , 438-449
MINIMALLY INVASIVE MAGNETIC RESONANCE IMAGING-GUIDED STEREOTACTIC RADIOFREQUENCY THERMOCOAGULATION FOR EPILEPTOGENIC HYPOTHALAMIC HAMARTOMAS
To validate the safety and efficacy of magnetic resonance imaging (MRI)-guided stereotactic radiofrequency thermocoagulation (SRT) for epileptogenic hypothalamic hamartoma (HH), we evaluated surgical outcomes and revised the MRI classification. We retrospectively reviewed 25 consecutive patients with HH (age range, 2-36 years; mean age, 14.8 years) with gelastic seizures. Other seizure types were exhibited in 22 patients (88.0%), precocious puberty in 8 (32.0%), behavioral disorder in 10 (40.0%), and mental retardation in 14 (56.0%). We classified HH into 3 subtypes according to coronal MRI: intrahypothalamic, parahypothalamic, and mixed hypothalamic type. Maximum diameter ranged from 8 to 30 mm (mean, 15.3 mm). All patients underwent SRT (74 degrees C, 60 seconds) for HH. HH subtype and size were correlated with precocious puberty, mental retardation, and behavioral disorder. Thirty-one SRT procedures were performed, requiring 1 to 8 tracks (mean, 3.8 tracks) and involving 1 to 18 lesions (mean, 7.2 lesions). There were no adaptive limitations, regardless of size or subtype. Mixed-type HHs needed more tracks and more lesions. No permanent complications persisted after SRT, and gelastic seizures disappeared in all but 2 patients. Complete seizure freedom was achieved in 19 patients (76.0%). These patients had not only disappearance of all seizure types and behavioral disorder but also intellectual improvement. The present SRT procedure has favorable efficacy and invasiveness and has no adaptive limitations. SRT should therefore be considered before adulthood. The new HH classification is useful to understand clinical symptoms and to determine surgical strategies.
- 1 December 2007
- Vol. 35 (12) , 1199-206
[Magnetic resonance imaging and pathology in epilepsy (5). Cavernous angioma and arteriovenous malformation].
- 1 December 2007
- Vol. 35 (12) , 1199-206
[Magnetic resonance imaging and pathology in epilepsy (5). Cavernous angioma and arteriovenous malformation].
- 1 October 2007
- Vol. 35 (10) , 1027-35
[Magnetic resonance imaging and pathology in epilepsy. (4) Tuberous sclerosis].
- 1 October 2007
- Vol. 35 (10) , 1027-35
[Magnetic resonance imaging and pathology in epilepsy. (4) Tuberous sclerosis].